- Home
- WWR vs CATX Comparison
WWR vs CATX Comparison
Compare WWR & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$0.89
HOLD
Current Price
$2.61
Company Overview
Basic Information| Metric | WWR | CATX |
|---|---|---|
| Founded | 1977 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Mining | Medical/Dental Instruments |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 157.8M | 162.8M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | WWR | CATX |
|---|---|---|
| Price | $0.89 | $2.61 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 9 |
| Target Price | $1.88 | ★ $11.56 |
| AVG Volume (30 Days) | ★ 2.1M | 1.9M |
| Earning Date | 11-12-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,075,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.45 | $1.60 |
| 52 Week High | $3.75 | $5.39 |
Technical Indicators
Market Signals| Indicator | WWR | CATX |
|---|---|---|
| Relative Strength Index (RSI) | 42.05 | 54.41 |
| Support Level | $0.95 | $2.07 |
| Resistance Level | $1.09 | $2.89 |
| Average True Range (ATR) | 0.10 | 0.18 |
| MACD | 0.02 | 0.09 |
| Stochastic Oscillator | 18.19 | 64.88 |
Price Performance
Historical Comparison WWR
CATX
About WWR Westwater Resources Inc.
Westwater Resources Inc focused on developing battery-grade natural graphite materials. The company is having one project which is the Westwater's coosa project which is currently used for the mining and extraction of graphite.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.